Health Hour

Dalmia Group coming up with “DHL Preventive capsule” to fight pandemic COVID-19

The Dalmia Group would be launching a Herbal Composition “DHL CoronaVirus Preventive Capsule” to fight the pandemic COVID-19. The medicine will be made available across all the pharmacies in Delhi NCR on 16th March 2020. The composition, which is priced at Rs 480 for 60 capsules, would also be available all over India through the online retail platform, “dalmiabestprice.in”.

Mr Sanjay Dalmia, Chairman, Dalmia Group of Companies, said, DHL Coronovirus Preventive capsule would work effectively on the immune system to further boost it. This polyherbal combination has anti-inflammatory effect which reduces any inflammation and congestion inside the lungs.

No side-effects, confirms study

This medicine has been developed after years of extensive research by the Dalmia Centre for Research and Development (DCRD). It is made up of 15 herbs called Astha-15, which are also mentioned in the Indian System of Medicine. The medicine has undergone a randomized double-blind, placebo-controlled study on patients, speciality Govt. Hospital for Thoracic medicine, Chennai, India.

As per the double-blind study using DCBT4567- dhl CoronaVirus, the patients tested had a significant reduction (95% significance) in dyspnoea, wheezing cough, disability and sleep disturbances. On a positive note, Astha-15 didn’t show any side-effects, which is a huge advantage for an allopathic drug.

COVID-19, which has affected about 87,000 people across the world, shows symptoms such as a running nose, cough, fever and body pain. The breathlessness caused by the virus is also due to the loss of the lining of the alveolar cells.

Due to the prominence of multiple active compounds, herbal medicine-derived natural products can be considered as an alternative therapeutic potential for respiratory diseases.

The presence of herbal compounds in Astha-15 would prevent the development of all the inflammatory processes triggered by an allergen, cigarette smoke, virus, or bacteria. Furthermore, it would reduce inflammatory cytokines release and oxidative stress.

You may like: Can COVID-19 crisis lead to stronger healthcare sector in India?

Recent Posts

Bengaluru’s Worsening Water Crisis Should be the Wake-Up Call for India and The World

Bengaluru is facing an acute shortage of 500 million litres of water every day, which…

2 days ago

The Aam Admi Party Conundrum: Will Kejriwal Run The Delhi Government From Prison?

Delhi's Chief Minister, Arvind Kejriwal, has been arrested by the Enforcement Directorate (ED) and will…

2 days ago

Planning to vote for Modi This Year? Wait! Give it a Read to Become an Informed Voter First

The Indian growth story has been famously dubbed the 'Amrit Kaal' by leaders and ministers…

1 week ago

Key Takeaways From Kovind Panel’s Report on One Nation One Election

The report highlights a two-step process in conducting nationwide simultaneous elections that needs many constitutional…

2 weeks ago

TEPA: How a $100 Billion Free Trade Agreement with EFTA will Benefit India?

India and the four European Free Trade Association (EFTA) countries—Iceland, Norway, Liechtenstein, and Switzerland—have finally…

2 weeks ago

All about India’s Fifth Generation Indigenous Fighter Jet AMCA

A 15,000 crore project has been cleared by the Cabinet Committee on Security(CCS) to design…

2 weeks ago